Executive Brief

  • Option Care Health, Inc. entered into a Fourth Amendment to its Amended and Restated First Lien Credit Agreement on September 22, 2025 (Item 1.01).
  • The Amendment refinances existing term loans with a new class bearing interest at Term SOFR + 1.75%, maturing seven years from the Amendment date (Item 1.01).
  • Incremental term loans of approximately $49.64 million were added at the same interest rate and maturity (Item 1.01).
  • The maturity date of revolving credit commitments was extended to the fifth anniversary of the Amendment date, with a springing maturity clause linked to Unsecured Notes repayment (Item 1.01).
  • Post-Amendment, the principal amount of First Lien Term Loan indebtedness is approximately $678 million (Item 1.01).
  • The Amendment involves multiple lenders including 2025 Refinancing Term Lenders, Incremental Term Lenders, Extending Revolving Credit Lenders, and Bank of America as administrative agent (Item 1.01).
  • The Amendment is incorporated by reference into Item 2.03 as a creation of a direct financial obligation (Item 2.03).
  • The full Amendment text is filed as Exhibit 10.1 (Item 9.01).
  • No new financial guidance, officer changes, or other Items were disclosed.
  • Key risk to monitor: impact of extended maturities and incremental debt on liquidity and covenant compliance.

Item-by-Item Analysis

Item 1.01 – Entry into a Material Definitive Agreement

  • What happened: Option Care Health entered into the Fourth Amendment to its Amended and Restated First Lien Credit Agreement on September 22, 2025.
  • Parties/terms:
    • Borrower: Option Care Health, Inc. and certain subsidiaries.
    • Lenders: 2025 Refinancing Term Lenders, 2025 Incremental Term Lenders, Extending Revolving Credit Lenders.
    • Administrative Agent: Bank of America, N.A.
    • Refinanced existing term loans with new term loans bearing interest at Term SOFR + 1.75%.
    • Maturity: Seven years from the Amendment effective date.
    • Incremental term loans: $49,639,386.20 at same interest rate and maturity.
    • Revolving credit commitments maturity extended to fifth anniversary of Amendment date, with springing maturity 91 days prior to Unsecured Notes maturity if any remain unpaid.
    • Post-Amendment principal amount of First Lien Term Loan indebtedness: approx. $678,000,000.
  • Conditions/closing: Not detailed beyond effective date of September 22, 2025.
  • Source: (Item 1.01, paras 1-4), (Exhibit 10.1).

Item 2.03 – Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

  • What happened: The Amendment described in Item 1.01 creates new direct financial obligations.
  • Source: Incorporated by reference from Item 1.01.

Item 9.01 – Financial Statements and Exhibits

  • Exhibit 10.1: Fourth Amendment to Amended and Restated First Lien Credit Agreement dated September 22, 2025.
  • Source: (Item 9.01), (Exhibit 10.1).

Exhibits Summary

  • Exhibit 10.1: Full text of the Fourth Amendment detailing refinancing terms, incremental loans, maturity extensions, and parties involved.

Financial & Dilution Impact

  • Incremental term loans of $49.64 million increase debt principal.
  • Total First Lien Term Loan principal post-Amendment approx. $678 million.
  • Interest rate lowered to Term SOFR + 1.75%.
  • Revolving credit maturity extended, potentially improving liquidity timing.
  • No equity dilution or share issuance disclosed.

Timeline & Required Actions

  • Amendment effective date: September 22, 2025.
  • Revolving credit maturity extended to September 22, 2030 (five years post-Amendment), subject to springing maturity clause.
  • No other approvals or filings disclosed.

Risks & Monitoring

  • Monitor impact of increased debt and extended maturities on covenant compliance and liquidity.
  • Watch for any triggers related to Unsecured Notes repayment affecting revolving credit maturity.
  • Interest rate exposure tied to Term SOFR fluctuations.

Metadata & Quality Checks

  • No OCR or parsing issues noted.
  • Non-GAAP reconciliation: Unknown.
  • Forward-looking statements: Not explicitly referenced.
  • Related-party transactions: None disclosed.

Final Checklist

  • Identified Items 1.01, 2.03, 9.01.
  • Extracted key financial terms and parties.
  • Summarized Exhibit 10.1 contents.
  • Quantified debt amounts and interest rates.
  • Noted effective dates and maturity extensions.
  • Highlighted risks and monitoring points.
  • No missing or contradictory information detected.

Original Filing